OPGN
CapForce Inc.
Key Financials
Operating Income
$324717
↑ 101.1%
Gross Profit
$924379
N/A
EPS (Diluted)
$2.30
↑ 105.5%
Revenue
$5.2M
↑ 52.0%
Total Assets
$9.9M
↑ 424.0%
Total Liabilities
$2.5M
↓ 81.5%
Net Income
$12.0M
↑ 136.7%
Shareholders' Equity
$7.4M
↑ 163.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 3/31/2026 | View on SEC |
| 8-K | 2/27/2026 | View on SEC |
| DEF 14A | 2/6/2026 | View on SEC |
| PRE 14A | 1/26/2026 | View on SEC |
| 8-K | 1/16/2026 | View on SEC |
| 8-K | 12/23/2025 | View on SEC |
| 3 | 12/10/2025 | View on SEC |
| 8-K | 12/5/2025 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OPGN |
| Company Name | CapForce Inc. |
| CIK | 1293818 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 301-869-9683 |